Prophylactic Dermatologic Treatment of Afatinib-Induced Skin Toxicities in Patients with Metastatic Lung Cancer: A Pilot Study
Articolo
Data di Pubblicazione:
2019
Abstract:
Severe skin rash is listed among important side effects of EGFR tyrosine kinase inhibitors. Polydatin (PD), a glycosylated polyphenol, is endowed with anti-inflammatory activity in human epidermal keratinocytes. Objective. +is study evaluated the effect topical application of a moisturizer containing PD to prevent skin rash in patients with mutated non-small cell lung cancer (NSCLC) treated with afatinib.
Tipologia CRIS:
01.01 Articolo in rivista
Keywords:
non-small cell lung cancer; Polydatin (PD); skin rash
Elenco autori:
Ravagnan, Giampietro; Fuggetta, MARIA PIA
Link alla scheda completa:
Pubblicato in: